Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio (2022 - 2025)

Historic Interest Coverage Ratio for Arrowhead Pharmaceuticals (ARWR) over the last 4 years, with Q4 2025 value amounting to 1.81.

  • Arrowhead Pharmaceuticals' Interest Coverage Ratio rose 12431.75% to 1.81 in Q4 2025 from the same period last year, while for Dec 2025 it was 3.33, marking a year-over-year increase of 12588.3%. This contributed to the annual value of 1.1 for FY2025, which is 10592.35% up from last year.
  • Per Arrowhead Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 1.81 for Q4 2025, which was up 12431.75% from 2.03 recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' 5-year Interest Coverage Ratio high stood at 17.62 for Q1 2025, and its period low was 34.58 during Q2 2024.
  • Its 4-year average for Interest Coverage Ratio is 9.77, with a median of 11.07 in 2024.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first plummeted by 28289.9% in 2024, then soared by 20112.72% in 2025.
  • Over the past 4 years, Arrowhead Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 14.79 in 2022, then plummeted by 72.03% to 25.44 in 2023, then skyrocketed by 70.69% to 7.46 in 2024, then soared by 124.32% to 1.81 in 2025.
  • Its last three reported values are 1.81 in Q4 2025, 2.03 for Q3 2025, and 6.79 during Q2 2025.